All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216275%3A25310%2F13%3A39896495" target="_blank" >RIV/00216275:25310/13:39896495 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11160/13:10145618 RIV/62157124:16170/13:43872135 RIV/62157124:16370/13:43872135 RIV/62157124:16810/13:43872135

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.bmc.2013.08.029" target="_blank" >http://dx.doi.org/10.1016/j.bmc.2013.08.029</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.bmc.2013.08.029" target="_blank" >10.1016/j.bmc.2013.08.029</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species

  • Original language description

    Three series of salicylanilides, esters of N-phenylsalicylamides and 2-hydroxy-N-[1-(2-hydroxyphenylamino)-1-oxoalkan-2-yl]benzamides, in total thirty target compounds were synthesized and characterized. The compounds were evaluated against seven bacterial and three mycobacterial strains. The antimicrobial activities of some compounds were comparable or higher than the standards ampicillin, cipro?oxacin or isoniazid. Derivatives 3f demonstrated high biological activity against Staphylococcus aureus (60.03 lmol/L), Mycobacterium marinum (60.40 lmol/L) and Mycobacterium kansasii (1.58 lmol/L), 3g shows activity against Clostridium perfringens (60.03 lmol/L) and Bacillus cereus (0.09 lmol/L), 3h against Pasteurella multocida (60.03 lmol/L) and M. kansasii(60.43 lmol/L), 3i against methicillin-resistant S. aureus and B. cereus (60.03 lmol/L). The structure?activity relationships are discussed for all the compounds.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    CC - Organic chemistry

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/ED1.1.00%2F02.0068" target="_blank" >ED1.1.00/02.0068: Central european institute of technology</a><br>

  • Continuities

    S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Bioorganic & Medicinal Chemistry

  • ISSN

    0968-0896

  • e-ISSN

  • Volume of the periodical

    21

  • Issue of the periodical within the volume

    21

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    8

  • Pages from-to

    6574-6581

  • UT code for WoS article

    000325164500032

  • EID of the result in the Scopus database